Catalyst Wire Dossier Catalyst Wire Dossier

Sutetinib Maleate Capsule

sutetinib maleate · Teligene US
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sutetinib Maleate Capsule, covering 2025-04-29 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC [Phase 2]

See pricing